To confirm the role of the mTOR pathway in the senescence of MSCs in SLE patients, we investigated the dose- and time-dependent inhibitory effects of RAPA on the mTOR pathway by measuring S6 phosphorylation, which is a significant marker of mTOR activity. Here, TRERF1 is linked to systemic lupus erythematosus.